Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000940180-99-000146
Filing Date
1999-02-12
Accepted
1999-02-12 00:00:00
Documents
3
Group Members
ANTHONY B. EVNINANTHONY SUNDAVID R. HATHAWAYKIMBERLEY A. RUMMELSBURGPATRICK F. LATTERELLRAY A. ROTHROCKTED H. MCCOURTNEYVENROCK ASSOCIATESVENROCK ASSOCIATES II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 39555
2 POWER OF ATTORNEY EX-24.1 3391
3 AGREEMENT EX-99.1 2821
  Complete submission text file 0000940180-99-000146.txt   48265
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47359 | Film No.: 99533393
SIC: 2834 Pharmaceutical Preparations